Deerfield Management’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-10,034
| Closed | -$273K | – | 632 |
|
|
2024
Q2 | $273K | Buy |
+10,034
| New | +$273K | ﹤0.01% | 359 |
|
|
2023
Q4 | – | Sell |
-754,042
| Closed | -$13.4M | – | 231 |
|
|
2023
Q3 | $13.4M | Buy |
+754,042
| New | +$13.4M | 0.3% | 51 |
|
|
2023
Q2 | – | Sell |
-1,156,032
| Closed | -$14.5M | – | 110 |
|
|
2023
Q1 | $14.5M | Sell |
1,156,032
-168,182
| -13% | -$2.11M | 0.32% | 61 |
|
|
2022
Q4 | $19.4M | Hold |
1,324,214
| – | – | 0.4% | 61 |
|
|
2022
Q3 | $22.7M | Hold |
1,324,214
| – | – | 0.45% | 60 |
|
|
2022
Q2 | $19.3M | Buy |
+1,324,214
| New | +$19.3M | 0.4% | 60 |
|